Unfortunately, in this article in the September 2019 issue of the European Respiratory Review, figure 2 was presented incorrectly. The correct figure is presented below. The article has been corrected and republished online.
FIGURE 2
A microRNA (miR)-21/phosphoinositide 3-kinase (PI3K)/histone deacetylase (HDAC)2 axis drives severe steroid-resistant asthma and may be targeted using miR-21 specific inhibitors (such as antagomir (Ant)-21) and/or PI3K inhibitors (such as LY294002). AAD: allergic airway disease; PTEN: phosphatase and tensin homologue.
- Copyright ©ERS 2019.
http://creativecommons.org/licenses/by-nc/4.0/
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
Vol 28 Issue 154
Table of Contents
“Cellular mechanisms underlying steroid-resistant asthma.” Ridhima Wadhwa, Kamal Dua, Ian M. Adcock, Jay C. Horvat, Richard Y. Kim and Philip M. Hansbro. Eur Respir Rev 2019; 28: 190021.
